The peptide blend may amplify GH release by targeting both GHRH and ghrelin receptors
Advanced imaging techniques, such as MRI and ultrasound, offer insights into tissue healing and adaptation at the molecular level
Contains no sugar, salt, starch, yeast, wheat, gluten, soy, milk, egg, shellfish or preservatives
Transition requires starting retatrutide at the beginning of its titration schedule (1mg) and working up, regardless of your previous tirzepatide dose
Section 3, labeled Inhibition of growth hormone, demonstrates the negative feedback mechanism where high levels of insulin-like growth factor-1 (IGF-1) are perceived by the hypothalamus, triggering the release of growth hormone-inhibiting hormone (GHIH, also called somatostatin)